[Event Report] The First Meeting of Working Group 5 on Vaccine Research and Development, “Next Actions for the Development and Implementation of Immunization and Vaccination Policies” (November 4, 2021)
date : 11/18/2021
Tags: Vaccinations
![[Event Report] The First Meeting of Working Group 5 on Vaccine Research and Development, “Next Actions for the Development and Implementation of Immunization and Vaccination Policies” (November 4, 2021)](https://hgpi.org/en/wp-content/uploads/sites/2/480362ac0216ccd54a95db275fbedadb-1.jpg)
On November 4, 2021, HGPI held the first meeting of Working Group 5 on vaccine research and development for “Next Actions for the Development and Implementation of Immunization and Vaccination Policies.”
During this meeting, the members deepened their discussion on topics such as the issues in Japan’s vaccine R&D pipeline that were highlighted during the Coronavirus pandemic and the establishment of R&D pipelines in non-emergency situations for the 100 Days Mission, which aims to develop a vaccine within 100 days after the confirmation of a new infectious disease was agreed upon by the G7. There were active discussions on the measures necessary by the industry, government, academia, and civil society to promote vaccine R&D, which has low economic rationality and provide no incentives to the companies.
Due to the circumstances regarding the COVID-19 pandemic, this meeting was held online.
2021 Advisory Board Working Group 5 (Titles omitted; in alphabetical order by last name)
Members:
Ken J. Ishii (Professor, Division of Vaccine Science, Institute of Medical Science, The University of Tokyo/ Director, International Vaccine Design Center, Institute of Medical Science)
Masayuki Imagawa (Chief Executive, Japan Vaccine Industry Association/ Vice President & Head, Japan Vaccine Business Unit, Takeda Pharmaceutical Co., Ltd.)
Hiroshi Kasanuki (Specially Appointed Professor, Waseda University/ Advisor, Institute for Medical Regulatory Science, Waseda University)
Kengo Sonoda (General Manager, Development Department, R&D Division, KM Biologics Co., Ltd.)
Hideki Hasegawa (Director, Center for Influenza and Respiratory Virus Research, National Institute of Infectious Diseases)
Yoshiharu Matsuura (Director, Center for Infectious Disease Education and Research (CiDER))
Shinji Matsumoto (Chair, Vaccines Working Team, EFPIA Japan)
Isao Miyairi (Professor, Faculty of Pediatrics, Hamamatsu University School of Medicine)
Yoshiaki Yamagishi (Associate Professor, Medical Center of Translational Research, Department of Medical Innovation, Osaka University)
Observer:
Yasuhiro Araki (Director, Office of Vaccine and Blood Products, Pharmaceuticals and Medical Devices Agency)
MC/Moderator:
Joji Sugawara (Manager, HGPI)
Opening Explanatory Introduction:
Ryoji Noritake (CEO/Board Member, HGPI)
Top Research & Recommendations Posts
- [Publication Report] Planetary Health Promotion Project “Issues Facing Planetary Health and the Role of the Health Sector” (May 10, 2023)
- [Research Report] 2019 Survey on Healthcare in Japan
- [Research Report] Building a Mental Health Program for Children and Measuring its Effectiveness (June 16, 2022)
- [Policy Recommendations] Building a Research and Development System Together With People Living with Dementia and Their Families to Drive Parallel Progress in Creating an Inclusive Society and Advancing R&D (April 25, 2023)
- [Public Comment Submission] Opinions Regarding the Proposed “National Action Plan on Antimicrobial Resistance 2023-2027 (Draft)” (March 16, 2023)
- [Recommendations] Recommendations for the G7 Hiroshima Summit in 2023 Necessary Actions for AMR Control, Starting with the Introduction of Pull Incentives (August 29, 2022)
- [Policy Recommendations] Recommendations for the G7 Hiroshima Summit by the C7 Global Health Working Group (April 20, 2023)
- [Policy Recommendations] Requests for the G7 Hiroshima Summit and Related Ministerial Meetings: Promoting Measures for Climate Change and Planetary Health That Keep Pace With the International Community (December 19, 2022)
- [Research Report] The Public Opinion Survey on Mental Health (August 12, 2022)
- [Recommendations] Restructuring Diagnostic Services and Achieving the Necessary Innovation to Promote AMR Control (May 26, 2023)
Featured Posts
-
2023-05-12
[Event Report] Recommendations to Prime Minister Fumio Kishida on the issue of antimicrobial resistance (AMR) in the G7 Hiroshima Summit Leaders’ Declaration (April 28, 2023)
-
2023-05-15
[Event Report] (Live Broadcasting) A Dementia Symposium Commemorating the G7 Health Ministers’ Meeting in Nagasaki “Collaboration in the International Community for Advancing Dementia Measures in a New Era” (May 14, 2023)
-
2023-05-18
[Event Report] A NAGASAKI Planetary Health Expert Meeting “From COP27 and COP15 to the G7 Hiroshima Summit: New Partnerships for Solving Climate, Environment, Biodiversity and Health Issues” (May 12, 2023)
-
2023-05-19
[RegistrationOpen] Health Policy Academy the 12th Session
-
2023-05-26
[Recommendations] Restructuring Diagnostic Services and Achieving the Necessary Innovation to Promote AMR Control (May 26, 2023)